CbdMD PE Ratio 2017-2024 | YCBD
Current and historical p/e ratio for CbdMD (YCBD) from 2017 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CbdMD PE ratio as of November 13, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CbdMD PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-11-12 |
0.50 |
|
0.00 |
| 2024-06-30 |
0.59 |
$-11.23 |
0.00 |
| 2024-03-31 |
0.93 |
$-12.24 |
0.00 |
| 2023-12-31 |
1.04 |
$-12.63 |
0.00 |
| 2023-09-30 |
1.04 |
$-15.56 |
0.00 |
| 2023-06-30 |
1.40 |
$-17.76 |
0.00 |
| 2023-03-31 |
8.78 |
$-41.38 |
0.00 |
| 2022-12-31 |
10.22 |
$-44.14 |
0.00 |
| 2022-09-30 |
10.13 |
$-56.31 |
0.00 |
| 2022-06-30 |
19.81 |
$-46.85 |
0.00 |
| 2022-03-31 |
46.80 |
$-21.17 |
0.00 |
| 2021-12-31 |
48.60 |
$-27.48 |
0.00 |
| 2021-09-30 |
93.60 |
$-19.82 |
0.00 |
| 2021-06-30 |
130.50 |
$-25.23 |
0.00 |
| 2021-03-31 |
186.30 |
$-34.23 |
0.00 |
| 2020-12-31 |
132.75 |
$-5.41 |
0.00 |
| 2020-09-30 |
90.00 |
$22.97 |
3.92 |
| 2020-06-30 |
85.95 |
$30.18 |
2.85 |
| 2020-03-31 |
41.85 |
$-15.32 |
0.00 |
| 2019-12-31 |
101.70 |
$-174.33 |
0.00 |
| 2019-09-30 |
178.20 |
$-197.30 |
0.00 |
| 2019-06-30 |
265.50 |
$-202.25 |
0.00 |
| 2019-03-31 |
198.90 |
$-147.30 |
0.00 |
| 2018-12-31 |
139.05 |
$1.35 |
102.89 |
| 2018-09-30 |
163.35 |
$4.05 |
40.29 |
| Sector |
Industry |
Market Cap |
Revenue |
| Business Services |
Advertising and Marketing Services |
$0.002B |
$0.024B |
|
cbdMD Inc. owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD. The company's current product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils and CBD pet products. cbdMD Inc., formerly known as Level Brands Inc., is based in Charlotte, United States.
|
